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Abstract
Rhabdomyosarcomas (RMS) are among the most common soft-tissue tumors in children. These tumors are derived 
from mesenchymal tissue with a tendency toward myogenic differentiation that probably originates from immature 
and highly invasive satellite cells associated with the embryogenesis of skeletal muscle. Some of these tumors are 
associated with high rates of recurrence and metastasis. The diagnosis is made by microscopic analysis and auxiliary 
techniques such as immunohistochemistry, electron microscopy, cytogenetic analysis, and molecular biology. We 
report here a case of orofacial RMS in a 4-year-old child and provide an updated review of the literature, focusing 
mainly on the clinicopathological aspects, diagnosis and treatment of RMS of the head and neck. 
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Introduction
Childhood soft-tissue tumors comprise a heterogeneous 
group of lesions, including rhabdomyosarcomas (RMS), 
the most common intracranial solid tumors in this popu-
lation (1-3).
RMS are malignancies derived from primitive mesen-
chymal tissues that exhibit a tendency toward myogenic 
differentiation and probably originate from satellite cells 
associated with the embryogenesis of skeletal muscle (1, 
4). RMS were initially described by Weber in 1854. The 
highest frequency of  these tumors is observed among 
white and African American children. A slight preference 
for males has been reported, with these tumors mainly 
occurring in the first and second decades of life (5). The 
etiology of RMS is unknown; however, a possible viral 
involvement in their pathogenesis has been suggested due 
to the identification of viral particles in malignant RMS 
tissues. Cytogenetic and molecular studies have identified 
chromosomal translocations and mutations in oncogenes, 
but the participation of these events in the etiology of 
RMS has not been well established (2, 6).
The head and neck are the most frequently affected regions, 
followed by the orbit (35% of cases) (7), trunk and extremi-
ties, intra-abdominal organs and genitourinary tract (23%). 
There are reports of cases arising in oral tissues, which 
correspond to 10 to 12% of all head and neck RMS and 
mainly involve the tongue, palate and oral mucosa (5). As a 
result of their aggressive neoplastic behavior characterized by 
immature and highly invasive cells, RMS are associated with 
high rates of recurrence and generalized metastases through 
the hematogenic and/or lymphatic routes. The diagnosis is 
generally made by microscopic analysis and auxiliary tech-
niques such as immunohistochemistry, electron microscopy, 
cytogenetic analysis, and molecular biology (8).
Histomorphologically, pediatric RMS are classified into 
embryonal RMS (66% of cases) which are characterized 
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by pronounced cellular pleomorphism, alveolar (28%), un-
differentiated (4%) and anaplastic RMS (2%). In addition, 
embryonal RMS are subdivided into botryoid and spindle 
cell subtypes (4, 5). The introduction of various treatment 
modalities has increased the survival of patients with RMS 
and some investigators have associated the prognosis with 
the location, evolutive stage and histological type of the 
tumor (9).
We report here the case of a child with orofacial RMS 
whose survival was limited because of a delay in the diag-
nosis. In addition, we present an updated review of the 
literature, focusing mainly on the clinical aspects, diagnosis 
and treatment of tumors of the head and neck.
Case Report
A 4-year-old black boy was seen in Aracajú city, Sergipe, 
Brazil, with a lesion located on the right side of the face. A 
previous incisional biopsy performed by a general patho-
logist from the same city had resulted in the histopatholo-
gical diagnosis of juvenile aggressive fibromatosis. 
After the initial diagnosis, medical contact with the patient 
was lost for reasons not specified by the child’s parents. Six 
months later, the parents sought medical care because the 
lesion exhibited progressive growth and painful symptoms 
(Figure 1). The boy was examined by the physician who 
initially attended him. A panoramic radiography revealed 
involvement of the ramus and body of the mandible, with 
the observation of a radiolucent lesion without defined 
limits and severe bone destruction (Figure 2A). Computed 
tomography confirmed the presence of an extensive infil-
trative lesion accompanied by severe bone destruction and 
displacement of adjacent structures (Figure 2B). Since the 
child’s family refused a second incisional biopsy, the lesion 
was removed surgically en bloc and part of the material 
collected was sent to the Laboratory of Pathological Ana-
tomy, Postgraduation Program in Oral Pathology, Federal 
University of Rio Grande do Norte, Natal, Brazil. Histo-
pathological analysis of  the hematoxylin/eosin-stained 
material showed fragments of  a tumor characterized 
by the proliferation of clear cells compactly arranged in 
solid masses and cords but without exhibiting a specific 
organizational pattern; the cells were sometimes separated 
by fibrous fillets and some of them were clustered in rows 
(Figure 3A). Cells with hyperchromatic nuclei, cellular and 
nuclear pleomorphism, and cells with slightly eosinophilic 
cytoplasm were also observed (Figure 3B). Mitotic figures, 
some of them aberrant, were noted (Figure 3C).
Since the histopathological findings were not characteristic 
of a specific tumor, immunohistochemistry was performed 
using myogenic and non-myogenic markers (desmin, 
smooth muscle actin, myoglobin, vimentin and S100 
protein). Staining was only positive for desmin (Figure 
3D). A diagnosis of Rhabdomyosarcoma (RMS) was es-
tablished on the basis of the clinical and histopathological 
characteristics.
Unfortunately, the patient died 2 months after the last 
surgical procedure without allowing the institution to 
provide any other adjuvant therapy. The patient’s parents 
received a detailed informed consent form stating that 
the case might be used for didactic purposes, which they 
signed authorizing the use of  the data and images for 
publication.
Fig. 2. (A) Panoramic radiograph showing ramus and body mandibular 
impairment, radiolucent lesion without defined limits and severe bone 
destruction, (B) CT – extensive infiltrative lesion with severe bone 
destruction and displacement of adjacent structures. 
Fig. 1. Lesion with swelling and facial as-
ymmetry.
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Discussion
The estimated incidence of RMS in Brazil is 7.8 cases 
per one million children younger than 15 years, with an 
incidence peak between 2 to 6 years of age (10). Approxi-
mately 35% of childhood RMS occur in the head and 
neck region, with involvement of the oral cavity being 
rare. These tumors exhibit a fast and aggressive growth, 
reaching large dimensions, and are generally painless (7). 
Childhood RMS located in the head and neck region have 
been associated with a more favorable prognosis than those 
arising at other anatomical sites, possibly due to the early 
evolutive stage of the tumor at the time of its detection 
at these sites (11). The case reported here agrees with the 
literature with respect to patient age and the fast and 
aggressive growth of the tumor accompanied by severe 
bone destruction.
According to the literature, clinical establishment of the 
differential diagnosis of RMS is difficult (5), a fact that 
can markedly affect the patient’s prognosis. Unfortunately, 
in the present case the lack of cooperation of the patient’s 
guardians and the lack of institution of adjuvant chemo-
therapy and/or radiotherapy at first admission, as well 
as the delay in the diagnosis of the first biopsy material, 
may have favored the rapid progression of the tumor and 
subsequently aggravated the severity of  the condition, 
resulting in the child’s death.
Patients with RMS may present signs and symptoms 
such as pain, paresthesia, loss of teeth and trismus as a 
result of factors such as advanced tumor stage, infiltra-
tive growth and tumor location (12). In the present case, 
involvement of some mandibular teeth was observed and 
the patient complained of painful symptoms associated 
with the tumor.
Differences exist in terms of the most common location 
of RMS in the oral cavity. However, analysis of the cases 
reported in the literature indicates that most of them occur 
in the palate and tongue. No preferential location was seen 
in the present patient, with the orofacial tumor involving 
the ramus and body of the mandible, an uncommon loca-
tion of RMS and therefore making this case unusual.
Similar to the difficulties in defining a clinical diagnosis, 
the histopathological diagnosis of  RMS is sometimes 
a delicate task since the tumor may exhibit nonspecific 
characteristics similar to those of other neoplasms, a fact 
requiring staining methods that are more specific than 
histopathological examination of  hematoxylin/eosin-
Fig. 3. (A) Clear cell proliferation clustered in rows, separated by fibers of the connective tissue. Hematoxylin and eosin stain. 200x; (B) Cells 
with slightly eosinophilic cytoplasm, with hipercromatic nuclei and pleomorphism. Hematoxylin and eosin stain. 400x; (C) Cellular and 
nuclear pleomorphism, mitosis figures. Hematoxylin and eosin stain. 400x; (D) Desmin immupositivity. Immunoperoxidase stain.  200x.
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stained specimens, particularly when the tumor is poorly 
differentiated. However, in some cases the histomorpho-
logical and immunohistochemical findings may not be 
sufficient to establish a precise diagnosis or are difficult to 
interpret within the clinical context (2). The case reported 
here illustrates this diagnostic difficulty as demonstrated 
by the different diagnostic hypothesis of the initial biopsy 
specimen raised by the physician who attended the patient 
at the first time. Since the initial diagnosis was made 
using an incisional biopsy fragment, the specimen may 
not have been representative of the architectural features 
of the tumor, a fact preventing the correct diagnosis on 
that occasion.
Although sufficient amount of  tissue was obtained 
for analysis during the second biopsy, the findings of 
nonspecific spindle-shaped and round cells, sometimes 
exhibiting clear cytoplasm and pleomorphism, upon 
analysis of hematoxylin/eosin-stained material led to the 
initial diagnosis of  a malignant neoplasm of  possible 
mesenchymal origin. Only immunohistochemical analysis 
using antibodies for the identification of the cytological 
origin of the tumor permitted the establishment of the 
final diagnosis of RMS.
Although no histological features suggestive of a specific 
RMS type were observed, considering the young age of the 
patient the possibility of embryonal RMS was raised, the 
most common type in this age group. On the other hand, 
the presence of diverse morphological features suggested 
pleomorphic RMS; however, this rather aggressive tumor 
type does not occur in children (1). In addition, it is known 
that embryonal RMS exhibits marked cellular pleomor-
phism. Franca et al. (7) reported the case of a patient with 
solid alveolar RMS. After immunohistochemical analysis, 
the subtype was changed to undifferentiated RMS due to 
its negativity for myogenin, desmin, muscle-specific actin, 
leukocyte common antigen, and cytokeratins. Considering 
this information and the positivity for desmin observed in 
the case reported here, the tumor might have been a not 
otherwise specified (NOS), a category recently added to 
the classification of RMS that was created for tumors that 
could not be classified into an specific subtype (4).
Myogenin and desmin are sensitive and specific im-
munohistochemical markers for head and neck RMS. 
Muscle-specific actin has also been considered as a mar-
ker for these tumors, but it is less sensitive (1, 13). Other 
immunohistochemical markers have been used to help 
with the difficult diagnosis of RMS, including myogenic 
nuclear regulatory proteins such as MyoD1 and myogenin 
that act as transcription factors and stimulate myogenesis 
(14). MyoD1 is a marker of the myoid lineage which is 
expressed by fetal myoblasts and is important for the 
transition from cell proliferation to differentiation. A 
variety of differentiated cell types can be converted into 
skeletal muscle after transfection with MyoD1 through 
the activation of muscle-specific genes (15). Myogenin 
is a myoid differentiation marker. In this respect, it has 
been reported that the loss of normal proliferation and 
differentiation control may theoretically lead to the for-
mation of RMS (16).
Analysis of  MyoD1 and myogenin expression should 
permit the identification of primitive, relatively undifferen-
tiated tumors such as RMS. However, since MyoD1 and 
myogenin are markers of skeletal muscle differentiation, 
they may also be expressed in other tumors that exhibit 
this differentiation type, such as rhabdomyomatous Wilms’ 
tumor, and in regenerative muscle fibers entrapped within 
any infiltrating tumor (14).
Unfortunately, in the present case MyoD1 and myogenin 
immunostaining could not be performed to help with the 
diagnosis of the tumor. However, we believe that the use 
of these markers would have made only a didactic con-
tribution, since the morphological findings and desmin 
immunopositivity provided sufficient evidence to establish 
the final diagnosis of RMS. Molecular biology techniques 
are currently used for the classification of RMS subtypes 
and may represent a valuable tool for the determination of 
histological tumor type based on specific genetic criteria, 
especially permitting the planning of appropriate thera-
peutic management and estimation of prognosis (8). 
Treatment of RMS consists of surgical resection, when 
possible, associated with multiagent chemotherapy and/
or radiotherapy. This treatment represents risks and is 
primarily defined by the extent, location and stage of the 
tumor (5). In the case reported here, the fast growth of the 
tumor and the severe impairment of general health of the 
patient did not permit the introduction of a neoadjuvant 
chemotherapy or radiotherapy protocol after surgical 
removal since the patient died within a short period of 
time, even before the final diagnosis was available.
In conclusion, the present case illustrates the difficulty in 
the diagnosis of RMS and emphasizes the importance of 
urgent medical care to detect any fast-growing lesions in 
children, to diagnose severe lesions in a timely fashion, 
and to establish an appropriate treatment plan aimed at 
improving prognosis and patient survival, since a correct 
initial management is important for the satisfactory prog-
nosis of any tumor.
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